Auto-injectors Market is expanding rapidly with Becton, Dickinson & Co. introducing the BD Intevi 1 mL two-step disposable autoinjector for enhanced delivery.
Auto-injector devices provide
instantaneous relief to those who suffer from various types of diseases and
injuries by delivering medicine via injection into the muscles. These devices
have now become indispensable parts of our lives. This is especially true for
those who suffer from allergies or have allergic reactions. With the aid of an
auto-injector, people suffering from such conditions can take pain-free
medicine immediately and can be able to lead normal lives. Growing cases of
anaphylaxis is one of the major factors aiding growth of the market. As per the
Allergy & Asthma Network, in the U.S., anaphylaxis has around 1.6 and 5.1%
prevalence in the U.S. Anaphylaxis is a severe, life-threatening allergic
reaction and its symptoms include skin rash, vomiting, nausea, and difficulty
in breathing. Physicians may prescribe epinephrine auto-injector for a child at
risk of severe anaphylaxis. Thus, such factors can stimulate growth of the
auto-injectors market.
Another key factor that could fuel
the development of the said market is increasing R&D efforts by companies
to develop cost-effective new technologies. Key companies are focused on
continuous research and development activities, in order to develop advanced
technologies at competitive prices. Hence, such factors can potentially augment
growth of the auto-injectors market. Recently, in October 2019, Becton, Dickinson & Co.
launched the BD Intevi 1 mL two-step disposable autoinjector for enhanced
delivery.
Some auto-injectors are perfect for
administering epinephrine and adrenaline in cases of emergencies. This is due
to the fact that the dosage is adjusted automatically and the proper dose is
given in cases where there is an emergency. For this reason, this type of
device is also ideal for administering theophylline, a powerful allergy
reliever. When it comes to regional impact, North America seems to be gaining
significant traction in the auto-injectors market. This is due to the presence
of well-established healthcare infrastructure and technological advancements in
medical devices in the region. Besides, high cases of asthma among children
could further accelerate the regional market growth. On the contrary, Asia
Pacific is another key region exhibiting positive signs due to high incidences
of diabetics and anaphylaxis due to food allergies.
That being said, there are various
other factors that could still limit the potential development of the market.
For instance, the availability of alternate drug delivery modes can pose major
challenges to the market growth. Besides, the development of nasal epinephrine
sprays and lack of adequate training for using auto-injectors could
significantly impede growth of the auto-injectors market in the near future.
Comments
Post a Comment